PortfoliosLab logoPortfoliosLab logo
ICU Medical, Inc. (ICUI)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US44930G1076
CUSIP
44930G107
IPO Date
Mar 31, 1992

Highlights

Market Cap
$3.19B
Enterprise Value
$4.18B
EPS (TTM)
$0.28
PE Ratio
469.34
PEG Ratio
10.99
Total Revenue (TTM)
$2.23B
Gross Profit (TTM)
$822.04M
EBITDA (TTM)
$242.40M
Year Range
$107.00 - $160.29
Target Price
$163.00
ROA (TTM)
0.17%
ROE (TTM)
0.32%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ICU Medical, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ICU Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

ICU Medical, Inc. (ICUI) has returned -9.48% so far this year and -6.99% over the past 12 months. Over the last ten years, ICUI has returned 2.28% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


ICU Medical, Inc.

1D
3.01%
1M
-14.23%
YTD
-9.48%
6M
7.66%
1Y
-6.99%
3Y*
-7.83%
5Y*
-9.04%
10Y*
2.28%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Mar 31, 1992, ICUI's average daily return is +0.08%, while the average monthly return is +1.37%. At this rate, your investment would double in approximately 4.2 years.

Historically, 53% of months were positive and 47% were negative. The best month was Jan 1993 with a return of +50.0%, while the worst month was Jun 1996 at -37.4%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ICUI closed higher 48% of trading days. The best single day was Sep 8, 2021 with a return of +26.2%, while the worst single day was Aug 8, 2019 at -33.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.07%0.45%-14.23%-9.48%
20255.92%-10.97%-5.10%-1.63%-1.27%-2.01%-2.83%-0.58%-6.03%0.11%23.61%-3.89%-8.06%
2024-8.23%19.34%-1.75%-8.76%8.60%11.67%6.93%30.20%10.22%-6.31%-3.97%-5.36%55.57%
202322.70%-11.69%-3.33%14.66%-7.53%1.89%-0.01%-18.60%-17.94%-17.60%-10.50%13.65%-36.66%
2022-10.10%10.95%-5.95%-3.89%-15.12%-9.50%7.77%-10.26%-5.28%-1.45%7.29%-1.10%-33.65%
2021-4.67%1.48%-0.99%1.38%-0.10%-1.09%-1.22%-1.94%17.07%0.32%-3.38%4.92%10.65%

Benchmark Metrics

ICU Medical, Inc. has an annualized alpha of 13.79%, beta of 0.66, and R² of 0.08 versus S&P 500 Index. Calculated based on daily prices since April 01, 1992.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (82.18%) than losses (71.55%) — typical of diversified or defensive assets.
  • Beta of 0.66 may look defensive, but with R² of 0.08 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.08 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
13.79%
Beta
0.66
0.08
Upside Capture
82.18%
Downside Capture
71.55%

Return for Risk

Risk / Return Rank

ICUI ranks 31 for risk / return — below 31% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


ICUI Risk / Return Rank: 3131
Overall Rank
ICUI Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
ICUI Sortino Ratio Rank: 2929
Sortino Ratio Rank
ICUI Omega Ratio Rank: 2929
Omega Ratio Rank
ICUI Calmar Ratio Rank: 3232
Calmar Ratio Rank
ICUI Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for ICU Medical, Inc. (ICUI) and compare them to a chosen benchmark (S&P 500 Index).


ICUIBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.17

0.90

-1.07

Sortino ratio

Return per unit of downside risk

0.04

1.39

-1.34

Omega ratio

Gain probability vs. loss probability

1.01

1.21

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.28

1.40

-1.68

Martin ratio

Return relative to average drawdown

-0.59

6.61

-7.20

Explore ICUI risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


ICU Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the ICU Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ICU Medical, Inc. was 73.82%, occurring on Nov 9, 2023. The portfolio has not yet recovered.

The current ICU Medical, Inc. drawdown is 58.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-73.82%Jun 15, 20181361Nov 9, 2023
-71.81%Jun 7, 199692Oct 16, 1996928Jun 21, 20001020
-53.08%Oct 13, 2006422Jun 18, 2008944Mar 16, 20121366
-49.92%Nov 25, 2002487Nov 1, 2004461Aug 30, 2006948
-47.83%Apr 8, 199349Jun 17, 1993155Jan 26, 1994204

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ICU Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how ICU Medical, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ICUI, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, ICUI has a P/E ratio of 469.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ICUI compared to other companies in the Medical Instruments & Supplies industry. ICUI currently has a PEG ratio of 11.0. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ICUI relative to other companies in the Medical Instruments & Supplies industry. Currently, ICUI has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ICUI in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ICUI has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items